VANCOUVER, BC, Aug 3, 2022 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health”) (CSE: NARA) is pleased to announce that its Nara App is now available for download in NorthAmerica on the Apple App Store and the Google Play Store. As one of Canada’s first publicly-traded benefit companies, PanGenomic Health is committed to providing consumers with personalized information about evidence-based natural remedy solutions to support mental health.
PanGenomic Health Inc. (CNW Group/PanGenomic Health Inc.)
“People are taking more control over their personal health decisions, and want access to evidence-based information about mental health solutions delivered in a consumer-friendly manner,” said Robert Nigren, Executive Chair of PanGenomic Health. ” With our Nara App, users can access, share and discuss trusted sources of information about treatments for mental health conditions in order to educate themselves about their own use of pharmaceutical and natural remedy medications.”
In a widely reported study published last month in Molecular Psychiatry led by researchers from University College London, the UK, Italian and Swiss researchers carried out a systematic review of the evidence for the serotonin chemical imbalance theory of depression. The researchers concluded that “This review suggests that the huge research effort based on the serotonin hypothesis has not produced convincing evidence of a biochemical basis for depression. This is consistent with research on many other biological markers. We suggest it is time to acknowledge that the serotonin theory of depression is not empirically substantiated.” [See: Moncrieff, J., Cooper, R.E., Stockmann, T. et al. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry (2022). https://doi.org/10.1038/s41380-022-01661-0].
The free Nara App includes a plant medicine library, curated articles, a mental wellness tracker, a community forum and access to DNA insight reports to learn how genetics may impact the effectiveness of natural remedy solutions.
About PanGenomic Health
PanGenomic Health Inc. is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Our initial focus is to support mental health. Registered as a British Columbia benefit company, PanGenomic Health’s mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.
For more product information, please visit www.nara.care or download the Nara App at:
Apple AppStore: www.apps.apple.com/us/app/care-with-nara/id1614523255
Google Play Store: www.play.google.com/store/apps/details?id=com.pgxmobileclient
This news release includes certain statements that may be deemed “forward-looking statements”, including statements respecting the services to be provided by PanGenomic and the consideration to be paid to PanGenomic. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward looking statements. Although PanGenomic believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward looking statements because PanGenomic can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in PanGenomic’s disclosure documents which can be found under PanGenomic’s profile on www.sedar.com.
The Canadian Securities Exchange has neither approved nor disapproved the information contained in and does not accept responsibility for the adequacy or accuracy of this news release.
SOURCE PanGenomic Health Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/August2022/03/c1555.html